Summary
The contractile function of the myocardium is coordinated by a fibrous matrix of exquisite organization and complexity. In the normal heart, and apparently in physiological hypertrophy, this matrix is submicroscopic. In pathological states changes are frequent, and usually progressive. Thickening of the many elements of the fine structure is due to an increased synthesis of Type I collagen, This change, which affects the myocardium in a global manner, can be observed by light microscopy using special techniques. Perivascular fibrosis, with an increase in vascular smooth muscle, is accompanied by development of fibrous septa, with a decrease in diastolic compliance. These structural changes are believed to be due to increased activation of the renin-angiotensin-aldosterone system, and to be independent of the processes of myocyte hypertrophy. Reparative or replacement fibrosis is a separate process by means of which small and large areas of necrosis heal, with the development of coarse collagen structures, which lack a specific organizational pattern. Regarding ischemic heart disease, an increase in tissue collagenase is found in experimental myocardial “stunning” and in the very early phase of acute infarction. Absence of elements of the fibrous matrix allow for myocyte slippage, and—if the affected area is large—cardiac dilatation. If, subsequently, the necrosis becomes transmural, there is further disturbance of collagen due to both mechanical strain and continued autolysis, During healing collagen synthesis increases greatly to allow for reparative scarring in the available tissue matrix. In cases of infarction with moderate or severe initial dilatation, pathological hypertrophy of the spared myocardium is progressive, accounting for late heart failure and poor survival. Experimental studies on hypertension indicate that proliferation of the fibrous matrix can be modified by ACE inhibition. Also, there are reports that thrombolysis may prevent cardiac enlargement. Appreciation of the role of the fine fibrous matrix of the ventricle and its various collagens in ischemic heart disease is fundamental to the pharmacological management of the various acute coronary syndromes and their short- and long-term clinical consequences.
Similar content being viewed by others
References
Caulfield JB, Borg TK. The collagen network of the heart.Lab Invest 1979;40:364–372.
Robinson TF, Cohen-Gould L, Factor SM. The skeletal framework of mammalian heart muscle: Arrangement of inter- and pericellular connective tissue structures.Lab Invest 1983;49:482–487.
Robinson TF, Geraci MA, Sonnenblick EH, Factor SM. Coiled perimysial fibers in the rat heart: Morphology, distribution, and changes in configuration.Circ Res 1988;63:577–592.
Grossman WH.Diastolic Relaxation of the Heart. Boston: Martinus-Nijhoff, 1988.
Kass DA, Wolff MR, Ting C-T, et al. Diastolic compliance of hypertrophied ventricle is not acutely altered by pharmacological agents influencing active processes.Ann Intern Med 1993;119:466–473.
Sonnenblick EH. Series elastic and contractile elements in heart muscle: Chances in muscle length.Am J Physiol 1964;207:1330–1338.
Glantz SA, Parmley WW. Factors which affect the diastolic pressure-volume curve.Circ Res 1978;42:171–180.
Frank JS, Langer GA. The myocardial interstitium: Its structure and its role in ionic exchange.J Cell Biol 1974;60:586–601.
Weber KT. Cardiac interstitium in health and disease: Fibrillary collagen network.J Am Coll Cardiol 1989;13:1637.
Iimoto DS, Covell JW, Harper E. Increase in cross linking of type I and type III collagens associated with volume overload hypertrophy.Circ Res 1988;63:399–408.
Borg TK, Ranson WF, Moslehy FA, Caulfield JB. Structural basis of ventricular stiffness.Lab Invest 1981;44:49–54.
Caspari PG, Newcomb M, Gibson K, Harris P. Collagen in the normal and hypertrophied human ventricle.Cardiovasc Res 1977;11:554–558.
Caulfield JB. Alterations in cardiac collagen with hypertrophy.Perspect Cardiovasc Res 1983;8:49–57.
Thiedmann KU, Holubarsch C, Medugorac I, Jacob R. Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical and mechanical parameters.Basic Res Cardiol 1983;78:140–155.
Weber KT, Janicki JS, Shroff SG, Pick R, Chen RL, Bashey RI. Collagen remodeling of the pressure overloaded hypertrophy nonhuman primate myocardium.Circ Res 1988;62:757–765.
Weber KT, Jahl JE, Janicki JS, Pick R. Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease.Am J Hypertens 1989;2:931–940.
Anversa P, Ricci R, Olivetti G. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: A review.J Am Coll Cardiol 1986;7:1140–1149.
Morgan HE, Baker KM. Cardiac hypertrophy: Mechanical, neural and endocrine dependence.Circulation 1991;83:13–25.
Weber KT, Brilla C. Pathological hypertrophy and the cardiac interstitium—Fibrosis and renin angiotension aldosterone system.Circulation 1991;83:1849–1865.
Laks MM, Morady GE, Swan HJC. Canine right and left ventricular cell and sarcomere length after banding the pulmonary aftery.Circ Res 1969;26:705–710.
Rastelli GC, Hallerman FJ, Fellows JL, Swan HJC. Cardiac performance during exercise in dogs with constricted pulmonary artery.Circ Res 1963;13:410–419.
Geha AS, Duffy JP, Swan HJC. Relation of increase in muscle mass to performance of hypertrophied right ventricle in the dog.Circ Res 1966;19:255–259.
Capasso JM, Palakal T, Olivetti G, Anversa P. Left ventricular failure induced by long-term hypertension in rats.Circ Res 1990;60:1400–1412.
Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats.Circ Res 1991;68:856–869.
Fishbein MC, MacLean D, Maroko PR. The histologic evolution of myocardial infarction.Chest 1978;73:843–849.
Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wave front phenomenon of ischemic cell death. Myocardial infarct size versus duration of coronary occlusion in dogs.Circulation 1977;56:786–794.
Charney RH, Takahashi S, Zhao M, Sonnenblick EH, Eng C. Collagen loss in the stunned myocardium.Circulation 1992;85:1483–1490.
Forrester JS, Diamond G, Parmley WW, Swan HJC. Early increase of left ventricular compliance after myocardial infarction.J Clin Invest 1972;51:598–603.
Capasso JM, Li P, Anversa P. Non-ischemic myocardial damage induced by non-occlusive constriction of coronary artery in rats.Am J Physiol 1991;260:H651-H661.
Olivetti G, Capasso JM, Sonnenblick EH, Anversa P. Side to side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats.Circ Res 1990;67:23–34.
Whittaker P, Boughner DR, Kloner RA. Role of collagen in acute myocardial infarction expansion.Circulation 1991;84:2123–2134.
Villanueva AG, Farber HW, Rounds S, Goldstein RH. Stimulation of fibroblast collagen and total protein formation by an endothelial derived cell factor.Circ Res 1991;69:134–141.
Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction.Prog Cardiovasc Dis 1987;30:73–110.
Swan HJC, Forrester JS, Diamond G, Chatterjee K, Parmley WW. Hemodynamic spectrum of myocardial infarction and cardiogenic shock: A conceptual model.Circulation 1972;45:1097–1109.
Shah PK, Pichler M, Berman D, et al. Left ventricular ejection determined by radionuclide ventriculography in early stages of first transmural myocardial infarction and its relationship to short term mortality and morbidity.Am J Cardiol 1980;45:542–546.
Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications.Circulation 1990;81:1161–1172.
Swan HJC, Shah PK, Rubin S. Role of vasodilators in the changing phases of myocardial infarction.Am Heart J 1982;103:707–715.
Weber KT, Anversa P, Armstrong PW, et al. Remodeling and reparation of the cardiovascular system.J Am Coll Cardiol 1992;20:3–16.
Factor SM, Robinson TF, Dominitz R, Cho S. Alterations of the myocardial skeletal framework in acute myocardial infarction with and without ventricular rupture.Am J Cardiovasc Pathol 1986;1:91–97.
Jugdutt BJ. Delayed effects of early infarct-limiting therapies on healing after myocardial infarction.Circulation 1985;72:907–914.
Lavie CJ, O'Keefe JH, Cheesbro JH, et al. Prevention of late ventricular dilatation after myocardial infarction by successful thrombolytic reperfusion.Am J Cardiol 1990;66:31–36.
Nolan SE, Mannsini JA, Bush DE, et al. Increased afterload aggravates infarct expansion after acute myocardial infarction.J Am Coll Cardiol 1988;12:1318–1325.
Parmley WW, Chuck L, Kivowitz C, Matloff J, Swan HJC. In vitro length tension relationships of human ventricular aneurysms.Am J Cardiol 1973;32:889–894.
GREAT Group. Fesibility, safety, and efficacy of domicillary thrombolysis by general practioners: Grampian Region Early Anistreplase Trial.Br Med J 1992;305:548–553.
Pahor M, Bernabei R, Sgadari A. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats.Hypertension 1991;18:148–157.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swan, H.J.C. Left ventricular dysfunction in ischemic heart disease: Fundamental importance of the fibrous matrix. Cardiovasc Drug Ther 8 (Suppl 2), 305–312 (1994). https://doi.org/10.1007/BF00877314
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00877314